Advisor Group Holdings, Inc. Cassava Sciences Inc Transaction History

Advisor Group Holdings, Inc.

$39.8 Billion
Q4 2024

A detailed history of Advisor Group Holdings, Inc. transactions in Cassava Sciences Inc stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 152,283 shares of SAVA stock, worth $424,869. This represents 0.0% of its overall portfolio holdings.

Number of Shares

152,283

Previous 153,020 0.48%

Holding current value

$424,869

Previous $4.5 Million 92.03%

% of portfolio

0.0%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 07, 2025	SELL	$2.29 - $32.18 $1,687 - $23,716	-737 Reduced 0.48%	152,283 $359,000
Q3 2024 Nov 13, 2024	BUY	$9.57 - $35.08 $637,457 - $2.34 Million	66,610 Added 77.09%	153,020 $4.5 Million
Q2 2024 Aug 13, 2024	BUY	$12.35 - $26.11 $47,868 - $101,202	3,876 Added 4.7%	86,410 $1.07 Million
Q1 2024 May 10, 2024	SELL	$18.44 - $26.41 $658,492 - $943,101	-35,710 Reduced 30.2%	82,534 $1.67 Million
Q4 2023 Feb 12, 2024	SELL	$12.64 - $30.11 $131,456 - $313,144	-10,400 Reduced 8.08%	118,244 $2.66 Million
Q3 2023 Nov 13, 2023	BUY	$16.64 - $25.32 $324,846 - $494,297	19,522 Added 17.89%	128,644 $2.14 Million
Q2 2023 Aug 10, 2023	SELL	$21.59 - $27.88 $209,207 - $270,157	-9,690 Reduced 8.16%	109,122 $2.68 Million
Q1 2023 May 12, 2023	BUY	$23.46 - $36.44 $554,735 - $861,660	23,646 Added 24.85%	118,812 $2.87 Million
Q4 2022 Feb 10, 2023	BUY	$27.82 - $44.16 $1.58 Million - $2.5 Million	56,659 Added 147.14%	95,166 $2.81 Million
Q3 2022 Nov 14, 2022	SELL	$16.33 - $51.06 $166,190 - $519,637	-10,177 Reduced 20.9%	38,507 $1.61 Million
Q2 2022 Aug 10, 2022	SELL	$17.22 - $38.47 $201,766 - $450,752	-11,717 Reduced 19.4%	48,684 $1.37 Million
Q1 2022 May 04, 2022	BUY	$32.6 - $53.05 $720,883 - $1.17 Million	22,113 Added 57.75%	60,401 $2.26 Million
Q3 2021 Nov 05, 2021	BUY	$41.79 - $135.3 $684,227 - $2.22 Million	16,373 Added 74.71%	38,288 $2.38 Million
Q2 2021 Aug 02, 2021	SELL	$32.15 - $89.72 $1.19 Million - $3.32 Million	-36,974 Reduced 62.79%	21,915 $1.87 Million
Q1 2021 May 13, 2021	BUY	$7.09 - $87.95 $316,320 - $3.92 Million	44,615 Added 312.56%	58,889 $2.65 Million
Q4 2020 Feb 10, 2021	SELL	$6.79 - $12.25 $38,268 - $69,041	-5,636 Reduced 28.31%	14,274 $97,000
Q3 2020 Nov 12, 2020	BUY	$2.86 - $11.51 $43,349 - $174,457	15,157 Added 318.89%	19,910 $229,000
Q2 2020 Aug 14, 2020	BUY	$2.04 - $9.64 $4,955 - $23,415	2,429 Added 104.52%	4,753 $14,000
Q1 2020 May 18, 2020	BUY	$3.26 - $9.65 $7,576 - $22,426	2,324 New	2,324 $9,000

Others Institutions Holding SAVA

# of Institutions

190

Shares Held

16.4M

Call Options Held

3.49M

Put Options Held

8.08M

View Full List

About CASSAVA SCIENCES INC

Ticker SAVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,097,900
Market Cap $112M
Description
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...

More about SAVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Account

Advisor Group Holdings, Inc. Cassava Sciences Inc Transaction History